List of Certificates of Suitability (CEPs) for cep_1997_007___rev_08 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for CEP 1997-007 - Rev 08 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl

score 20 · Accepted Answer

Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

One of their significant offerings is Cefalexin monohydrate, Powder, compacted, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 1997-007 - Rev 08

This Chemical Type CEP, issued on June 12, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 708 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for cep_1997_007___rev_08 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Centrient Pharmaceuticals

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

2 INTERVIEW #SpeakPharma

1 VLOG #PharmaReel

19 CORPORATE CONTENT #SupplierSpotlight

73 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

KEY PRODUCTS

INSPECTIONS & REGISTRATIONS

Filters

CEP 1997-007 - Rev 08

Valid

Chemical

2024-06-12

708

01

Looking for Certificates of Suitability (CEPs) for CEP 1997-007 - Rev 08 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl